TCL Archive NCI Programs to Average Eight Percent Increase Over ’87 Under House Total, Bit Some Would Vary August 14, 1987
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive Guest Editorial: Learning from the Power Morcellation Fiasco: Government Must Do More to Regulate Devices September 12, 2014